Sinovac Coronavirus Vaccine
- All
- News
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Thailand To Mix Sinovac, AstraZeneca Jabs "To Boost Protection Against Delta Variant"
Thailand's immunisation strategy against the coronavirus will see a shot of AstraZeneca's viral vector vaccine administered after one dose of Sinovac's vaccine, its health minister said on Monday.
-
Countries Relying On Chinese Vaccines Reporting Covid Surge: Report
Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.
-
China Authorises CoronaVac COVID-19 Vaccine For Children Above 3 Years
China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
Chinese Sinovac Shot Seen As Highly Effective In Study
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials
Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction
-
Turkey To Start Using China's COVID-19 Vaccine After Strong Results
Turkey will receive its first shipment of China's Sinovac coronavirus vaccine within days as preliminary domestic tests showed it was 91% effective, Health Minister Fahrettin Koca said on Thursday.
-
Chinese Covid Vaccine "Reached Efficacy Threshold": Brazil Institute
Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Thailand To Mix Sinovac, AstraZeneca Jabs "To Boost Protection Against Delta Variant"
Thailand's immunisation strategy against the coronavirus will see a shot of AstraZeneca's viral vector vaccine administered after one dose of Sinovac's vaccine, its health minister said on Monday.
-
Countries Relying On Chinese Vaccines Reporting Covid Surge: Report
Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.
-
China Authorises CoronaVac COVID-19 Vaccine For Children Above 3 Years
China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
Chinese Sinovac Shot Seen As Highly Effective In Study
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials
Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction
-
Turkey To Start Using China's COVID-19 Vaccine After Strong Results
Turkey will receive its first shipment of China's Sinovac coronavirus vaccine within days as preliminary domestic tests showed it was 91% effective, Health Minister Fahrettin Koca said on Thursday.
-
Chinese Covid Vaccine "Reached Efficacy Threshold": Brazil Institute
Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
